Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

$6 Million Biotech Should Provide A Short-term Double

I'm working on a new biotech company that should provide investors with a short-term double. This is a company that should be valued at more than $15 million but is currently trading at $6 million. There have been no negative events that have driven the price this low, this is just an example of Wall Street's ability to severely misprice micro caps.